Loading clinical trials...
Loading clinical trials...
Recombinant Human Growth Hormone (rHGH) for Knee Osteoarthritis (KORR): a Pilot, Randomized Placebo-controlled Trial
Conditions
Interventions
Somatropin (recombinant human growth hormone)
bacteriostatic saline placebo
Locations
1
Canada
Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada
Start Date
October 31, 2025
Primary Completion Date
July 1, 2028
Completion Date
January 1, 2029
Last Updated
March 16, 2026
NCT07302724
NCT07544693
NCT07481461
NCT06758388
NCT07078149
NCT04833946
Lead Sponsor
Dr. David Wasserstein
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions